Intuitive Surgical, Inc. $ISRG Shares Newly Acquired by Advisors Asset Management Inc.

Advisors Asset Management Inc. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 23,567 shares of the medical equipment provider’s stock, valued at approximately $9,583,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Fairscale Capital LLC raised its holdings in Intuitive Surgical by 3.5% during the third quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock worth $279,000 after purchasing an additional 22 shares during the last quarter. Beaumont Financial Advisors LLC grew its stake in Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 23 shares during the last quarter. Hughes Financial Services LLC grew its stake in Intuitive Surgical by 40.7% in the 3rd quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 24 shares during the last quarter. Blue Fin Capital Inc. grew its stake in Intuitive Surgical by 0.5% in the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after acquiring an additional 25 shares during the last quarter. Finally, Red Spruce Capital LLC increased its holdings in Intuitive Surgical by 4.1% during the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 25 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the completion of the transaction, the executive vice president directly owned 6,236 shares of the company’s stock, valued at $2,857,023.40. This trade represents a 6.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $457.34, for a total value of $4,573,400.00. Following the completion of the sale, the director directly owned 1,194,530 shares of the company’s stock, valued at approximately $546,306,350.20. This represents a 0.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 39,363 shares of company stock valued at $17,738,749. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $399.06 on Friday. The business’s 50-day moving average is $423.51 and its two-hundred day moving average is $427.91. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The firm has a market capitalization of $138.33 billion, a PE ratio of 48.25, a price-to-earnings-growth ratio of 2.75 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company posted $2.40 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ISRG. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Finally, KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $495.90.

Get Our Latest Stock Analysis on Intuitive Surgical

Trending Headlines about Intuitive Surgical

These are some of the ISRG headlines that stood out recently:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

About Intuitive Surgical

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Featured Articles

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.